Role of Salbutamol and Furosemide in TTN

Phase 3CompletedNCT03208894

Armed Forces Hospital, Pakistan100 enrolled

Overview

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

100

Conditions

Transient Tachypnea of the Newborn

Interventions

Furosemide InjectionDRUG

efficacy of salbutamol and furosemide in TTN

Eligibility

Sex: ALLMin age: 1 HourMax age: 7 Days

Medical Language ↔ Plain English

Inclusion Criteria: * all newborn babies with clinically diagnosed TTN Exclusion Criteria: * babies less than 34 weeks babies with congenital malformations and CHD

Locations (2)

Department of Pediatrics

Rawalpindi, Punjab Province, Pakistan

Military Hospital

Rawalpindi, Punjab Province, Pakistan

Outcomes

Primary Outcomes

duration of oxygen requiremment in neonates having TTN.

neonates will be subjected to treatment with furosemide and sabutamol and the duration of oxygen dependecy will be assessed.

Time frame: upto 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.